SIR selects Charles E. Ray Jr., MD, PhD, FSIR, and Brian F. Funaki, MD, FSIR, to serve as incoming JVIR co-editors-in-chief
New co-editors-in chief begin work in 2026
SIR is pleased to announce that Charles E. Ray Jr., MD, PhD, FSIR, a past president of SIR, and Brian F. Funaki, MD, FSIR, a past chair of the SIR Annual Scientific Meeting, have been selected as the incoming co-editors-in-chief of SIR’s flagship publication, the Journal of Vascular and Interventional Radiology (JVIR).
Dr. Ray, professor of radiology at the University of Utah School of Medicine, brings to the role more than a decade of editorial experience working with a number of scholarly publications, including having served as editor-in-chief of Seminars in Interventional Radiology since 2012. Dr. Funaki, professor of radiology and chief of vascular and interventional radiology at the University of Chicago Medical Center, has also served on editorial roles for numerous journals, including currently as deputy editor for JVIR. Drs. Ray and Funaki have previously served as co-editors on several publications, including SIR's Updates in Interventional Radiology series.
This editorship represents the first time in JVIR history that the role will be shared between two editors-in-chief. Drs. Ray and Funaki will officially begin their role in January 2026, as outgoing editor-in-chief Daniel Y. Sze, MD, PhD, FSIR, concludes his term of visionary leadership for the journal.
“Our wide-ranging search yielded a robust pool of applicant with a clear vision for solidifying JVIR as the home of IR research, and we are pleased that Drs. Ray and Funaki have agreed to join forces to provide their expertise and insights as the co-editors-in-chief of JVIR,” said Alda L. Tam, MD, MBA, FSIR, chair of the search committee and immediate past-president of SIR. “This co-editorship will allow JVIR to continue its 34-year tradition of publishing gold-standard IR research, while also accommodating a growing number of submissions each year.”
“JVIR has long stood at the pinnacle of IR research publishing and, together, Dr. Funaki and I look forward to identifying and publishing the work that will be most impactful to improving patient care over time,” said Dr. Ray.
“IR has always been on the leading edge of innovation medicine, and this new co-editorship will help us define that leading edge of the best research IR has to offer, in formats that have proven most valuable to the community,” Dr. Funaki said.
SIR thanks Dr. Sze for his transformative leadership and the JVIR Editor-in-chief Search Committee for its time and dedication: